Stockscreener 앱 받기
49.73
5.54%
2.61
Anaptysbio Inc 주식(ANAB)의 최신 뉴스
Bear Alert: Is AnaptysBio Inc undervalued by DCF analysisDollar Strength & Daily Stock Trend Reports - baoquankhu1.vn
AnaptysBio (NASDAQ:ANAB) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
ANAPTYBIO INC (NASDAQ:ANAB) Offers High-Growth Momentum and a Bullish Technical Setup - Chartmill
AnaptysBio, Inc. (ANAB) Stock Analysis: Biotechnology Innovator with 43.50% Upside Potential - DirectorsTalk Interviews
Assessing AnaptysBio (ANAB) Valuation As Technical Strength Meets Improving Profitability Prospects - Sahm
CD122’s double whammy makes for intriguing target - BioWorld MedTech
Understanding the Setup: (ANAB) and Scalable Risk - Stock Traders Daily
Treasury Yields: Will AnaptysBio Inc benefit from geopolitical trendsJuly 2025 Recap & Expert Approved Trade Ideas - baoquankhu1.vn
Barclays Raises Price Target for AnaptysBio (ANAB) to $78.00 | A - GuruFocus
Did Big EPS, Revenue Jump and JPM Spotlight Just Shift AnaptysBio's (ANAB) Investment Narrative? - simplywall.st
ANAPTYSBIO INC (NASDAQ:ANAB) Shows Minervini Trend Template and High-Growth Momentum Alignment - Chartmill
AnaptysBio Shares Face Pressure Amid Insider Sale and Strategic Uncertainty - AD HOC NEWS
Anaptysbio director Marquet sells $530k in shares By Investing.com - Investing.com Australia
Market Leaders: Is AnaptysBio Inc stock a good dividend stock2025 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
AnaptysBio (NASDAQ:ANAB) Director Magda Marquet Sells 11,000 Shares - MarketBeat
Anaptysbio director Marquet sells $530k in shares - Investing.com
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Breakout Zone: Can AnaptysBio Inc generate free cash flowWeekly Stock Analysis & Real-Time Volume Trigger Notifications - baoquankhu1.vn
AnaptysBio (NASDAQ:ANAB) Stock Price Down 7.3%Time to Sell? - MarketBeat
Rally Mode: Is AnaptysBio Inc a momentum stock2025 Winners & Losers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
AnaptysBio Teases 2026 Split, JEMPERLI Royalty Upside and Key Clinical Catalysts at JPM Conf - MarketBeat
ANAB: Separation into two focused entities targets value creation, with major clinical and royalty catalysts ahead - TradingView — Track All Markets
What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally - AOL.com
AnaptysBio (NASDAQ:ANAB) Stock Price Up 7.2%Time to Buy? - MarketBeat
AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation By Investing.com - Investing.com Canada
Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock By Investing.com - Investing.com Nigeria
Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock - Investing.com Australia
What Investors Should Know About a $163K AnaptysBio Insider Sale - sharewise.com
Why AnaptysBio Inc. stock could rally in 2025GDP Growth & Free Safe Capital Growth Stock Tips - ulpravda.ru
Anaptysbio CLO Loumeau sells $98,809 in shares By Investing.com - Investing.com UK
Assessing AnaptysBio (ANAB) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty - ET Pharma
Anaptysbio CEO Faga sells $638k in shares By Investing.com - Investing.com South Africa
Anaptysbio CEO Faga sells $638k in shares - Investing.com
Anaptysbio (ANAB) chief medical officer sells $163,191 in stock By Investing.com - Investing.com UK
Anaptysbio CFO Mulroy sells $112k in shares By Investing.com - Investing.com Canada
AnaptysBio (NASDAQ:ANAB) CFO Dennis Mulroy Sells 2,515 Shares - MarketBeat
Eric Loumeau Sells 2,210 Shares of AnaptysBio (NASDAQ:ANAB) Stock - MarketBeat
Paul Lizzul Sells 3,650 Shares of AnaptysBio (NASDAQ:ANAB) Stock - MarketBeat
Anaptysbio CLO Loumeau sells $98,809 in shares - Investing.com
The Technical Signals Behind (ANAB) That Institutions Follow - Stock Traders Daily
What AnaptysBio (ANAB)'s Royalty Spin-Off Plan Means For Shareholders - Sahm
AnaptysBio files motion to dismiss in Tesaro/GSK royalty dispute By Investing.com - Investing.com Nigeria
2.09%
0.48%
자본화:
|
볼륨(24시간):